Treffer 1 - 5 von 5 für Suche 'Hasimllari, Egla', Suchdauer: 0,50s Treffer weiter einschränken
  1. 1
    DefenCath Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adults

    DefenCath Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adults von Hasimllari, Egla, Cassandra, Doyno

    Veröffentlicht in Drug Topics

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Vivjoa Approved for Recurrent Vulvovaginal Candidiasis

    Vivjoa Approved for Recurrent Vulvovaginal Candidiasis von Hasimllari, Egla, Doyno, Cassandra R

    Veröffentlicht in Drug Topics

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    DefenCath Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adults: This new drug utilizes the bactericidal properties of taurolidine and the blood-thinning effects of heparin to maintain catheter patency

    DefenCath Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adults: This new drug utilizes the bactericidal properties of taurolidine and the blood-thinnin... von Hasimllari, Egla, Doyno, Cassandra

    Veröffentlicht in Drug topics

    Volltext
    Magazinearticle

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Lecanemab-irmb Approved for Alzheimer Disease

    Lecanemab-irmb Approved for Alzheimer Disease von Hasimllari, Egla, Chamberlin, Kevin

    Veröffentlicht in Drug Topics

    Volltext
    Magazinearticle

    Zu den Favoriten
    Gespeichert in:
  5. 5
    Vivjoa Approved for Recurrent Vulvovaginal Candidiasis: Oteseconazole is a treatment option for those living with a previously unmet medical need

    Vivjoa Approved for Recurrent Vulvovaginal Candidiasis: Oteseconazole is a treatment option for those living with a previously unmet medical need von Hasimllari, Egla, Doyno, Cassandra R

    Veröffentlicht in Drug topics

    Volltext
    Magazinearticle

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: